$2.44T
Total marketcap
$73.76B
Total volume
BTC 50.72%     ETH 14.89%
Dominance

Memphasys Limited IG7.F Stock

0.002 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
7.51M EUR
LOW - HIGH [24H]
0.0020 - 0.0020 EUR
VOLUME [24H]
5K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Memphasys Limited Price Chart

Memphasys Limited IG7.F Financial and Trading Overview

Memphasys Limited stock price 0.0020 EUR
Previous Close 0.0065 EUR
Open 0.007 EUR
Bid 0.007 EUR x 0
Ask 0.02 EUR x 0
Day's Range 0.007 - 0.007 EUR
52 Week Range 0.0045 - 0.03 EUR
Volume 400K EUR
Avg. Volume 0 EUR
Market Cap 11.24M EUR
Beta (5Y Monthly) 0.101915
PE Ratio (TTM) N/A
EPS (TTM) 0 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

IG7.F Valuation Measures

Enterprise Value 9.13M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 156.4056
Price/Book (mrq) 0.70000005
Enterprise Value/Revenue 127.029
Enterprise Value/EBITDA -2.986

Trading Information

Memphasys Limited Stock Price History

Beta (5Y Monthly) 0.101915
52-Week Change -70.73%
S&P500 52-Week Change 20.43%
52 Week High 0.03 EUR
52 Week Low 0.0045 EUR
50-Day Moving Average 0.00856 EUR
200-Day Moving Average 0.0083425 EUR

IG7.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 959.52M
Float 379.63M
Short Ratio N/A
% Held by Insiders 62.06%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -4354.49%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -12.80%
Return on Equity (ttm) -25.42%

Income Statement

Revenue (ttm) 71.85K EUR
Revenue Per Share (ttm) 0 EUR
Quarterly Revenue Growth (yoy) -68.50%
Gross Profit (ttm) 62.24K EUR
EBITDA -3056150 EUR
Net Income Avi to Common (ttm) -2327579 EUR
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.1M EUR
Total Cash Per Share (mrq) 0.002 EUR
Total Debt (mrq) 5.46M EUR
Total Debt/Equity (mrq) 57.3 EUR
Current Ratio (mrq) 0.711
Book Value Per Share (mrq) 0.01

Cash Flow Statement

Operating Cash Flow (ttm) 317.66K EUR
Levered Free Cash Flow (ttm) -4601668 EUR

Profile of Memphasys Limited

Country Germany
State NSW
City Homebush
Address 30 Richmond Road
ZIP 2140
Phone 61 2 8415 7300
Website https://www.memphasys.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.

Q&A For Memphasys Limited Stock

What is a current IG7.F stock price?

Memphasys Limited IG7.F stock price today per share is 0.0020 EUR.

How to purchase Memphasys Limited stock?

You can buy IG7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Memphasys Limited?

The stock symbol or ticker of Memphasys Limited is IG7.F.

Which industry does the Memphasys Limited company belong to?

The Memphasys Limited industry is Biotechnology.

How many shares does Memphasys Limited have in circulation?

The max supply of Memphasys Limited shares is 3.75B.

What is Memphasys Limited Price to Earnings Ratio (PE Ratio)?

Memphasys Limited PE Ratio is now.

What was Memphasys Limited earnings per share over the trailing 12 months (TTM)?

Memphasys Limited EPS is 0 EUR over the trailing 12 months.

Which sector does the Memphasys Limited company belong to?

The Memphasys Limited sector is Healthcare.